Takanori Nakajima
Takanori Nakajima publishes mostly in Immunology, Molecular Biology and Pharmacology, on topics such as Atherosclerosis and Cardiovascular Diseases, Pharmacy and Medical Practices and Antioxidant Activity and Oxidative Stress.
- World rank
- #6,367,740 of 7,710,434 ranked researchers
- Rank in Japan
- #251,606 of 383,136
- Works
- 64
- Citations
- 1.1k
- Citations per work
- 16.6
What does Takanori Nakajima research?
Takanori Nakajima's work is mostly in Biochemistry, Genetics and Molecular Biology (13%), Immunology and Microbiology (9%), Pharmacology, Toxicology and Pharmaceutics (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else4570.3%
- Life Sciences1726.0%
- Health Sciences23.7%
- Medicine23.7%
- 1Immunology9% of their works
- 2Molecular Biology7% of their works
- 3Pharmacology4% of their works
- 4Endocrinology, Diabetes and Metabolism4% of their works
- 5Biochemistry3% of their works
- 6Clinical Biochemistry3% of their works
Research topics
- Atherosclerosis and Cardiovascular Diseases
- Pharmacy and Medical Practices
- Antioxidant Activity and Oxidative Stress
- Amino Acid Enzymes and Metabolism
- Protease and Inhibitor Mechanisms
- Glycosylation and Glycoproteins Research
- Peroxisome Proliferator-Activated Receptors
- Analytical Methods in Pharmaceuticals
Which keywords describe Takanori Nakajima's research?
The keywords of their largest research topics: Inflammation, Atherosclerosis, Cancer, Clinical Pharmacy, Immune Response, Oxidized LDL, Pharmaceutical Care and Antioxidants.
- Pharmaceutical Analysis
- PPARs
- Green Analytical Chemistry
- Glycans
- Amino Acid Transporters
- Antioxidants
- Oxidized LDL
- Clinical Pharmacy
- Atherosclerosis
- Inflammation
- Cancer
- Immune Response
- Pharmaceutical Care
- Oxidative Stress
- D-Serine
- Glycosylation
- Matrix Metalloproteinases
- Peroxisome Proliferator-Activated Receptors
- Tissue Inhibitors of Metalloproteinases
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Inflammation123 topics
- Atherosclerosis92 topics
- Cancer62 topics
- Clinical Pharmacy51 topic
- Immune Response51 topic
- Oxidized LDL51 topic
- Pharmaceutical Care51 topic
- Antioxidants41 topic
- Oxidative Stress41 topic
- Amino Acid Transporters31 topic
- D-Serine31 topic
- Glycans31 topic
- Glycosylation31 topic
- Green Analytical Chemistry31 topic
- Matrix Metalloproteinases31 topic
- PPARs31 topic
- Peroxisome Proliferator-Activated Receptors31 topic
- Pharmaceutical Analysis31 topic
- Tissue Inhibitors of Metalloproteinases31 topic
Where does Takanori Nakajima work?
Takanori Nakajima's main affiliation in the publication record is Nihon Pharmaceutical University, Japan.
How many publications and citations does Takanori Nakajima have?
OpenAlex counts 64 works and 1,062 citations for Takanori Nakajima, an h-index of 14, ranking #6,367,740 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Takanori Nakajima. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.